8 Best CBD Stocks to Buy Right Now
The CBD sector is showing signs of entering a more mature and sustainable growth phase. This shift is drawing renewed investor attention to CBD stocks.
Jazz Pharmaceuticals Plc (JAZZ)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ardsley Partners Philip Hempleman | 30,000 | $7,229,100 | 0.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $103.00 | 1,621 | $166,961.54 | 101,621 | 2025-05-12 | Filing | |
| $99.71 | 100 | $9,971.00 | 100,000 | 2025-05-09 | Filing | |
| $98.91 | 19,216 | $1,900,677.62 | 99,900 | 2025-05-09 | Filing | |
| $98.10 | 80,684 | $7,915,471.55 | 80,684 | 2025-05-09 | Filing | |
| $119.65 | 12,000 | $1,435,800.00 | 27,932 | 2024-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $240.47 | 6,000 | $1,442,820.00 | 366,682 | 2026-07-01 | Filing | |
| $230.55 | 1,157 | $266,746.35 | 9,680 | 2026-06-15 | Filing | |
| $231.83 | 1,200 | $278,196.00 | 51,549 | 2026-06-10 | Filing | |
| $235.12 | 6,000 | $1,410,720.00 | 372,682 | 2026-06-01 | Filing | |
| $236.97 | 1,192 | $282,468.24 | 52,626 | 2026-05-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 968,092 | $233,281,128 | 0.2% | |
| 2. | 200,072 | $48,211,350 | 1.52% | |
| 3. | 126,539 | $30,492,103 | 0.5% | |
| 4. | 104,264 | $25,124,496 | 0.36% | |
| 5. | 68,560 | $16,520,903 | 0.23% |
News See All
10 Best European Growth Stocks to Buy
European growth stocks are getting another look as investors search for earnings growth outside the usual U.S. mega-cap playbook.
Here's What Analysts Are Saying About Jazz Pharmaceuticals (JAZZ) Post Q1 Results
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best healthcare stocks to buy for the long term.
10 Best Healthcare Stocks to Buy for the Long Term
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived, especially when compared...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals plc 2026 first quarter earnings conference call. At this time, all participants are in a listen-only mode.
10 Best Fast Growth Stocks to Invest In Now
Fast-growth stocks are getting a fresh look as the market no longer only looks at a small group of mega-cap names.
Raymond James Resumes Coverage of Jazz Pharmaceuticals (JAZZ) With an Outperform Rating
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the most undervalued biotech stocks to buy right now. On April 10, Raymond James resumed coverage of Jazz Pharmaceuticals (NASDAQ:JAZZ) with an Outperform...
8 Most Undervalued Biotech Stocks to Buy Right Now
On April 13, Tom Lee, Fundstrat's head of research, appeared on CNBC’s 'Power Lunch' to talk about his outlook on equities, what to expect in a wartime economy, and more.
Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate
On February 25, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) reported Q4 revenue of $1.2 billion, exceeding consensus estimates of $1.17 billion and marking 10% year-over-year growth.
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now.
Hedge Fund Resource Center